MedPath

天大医药科技(珠海)有限公司

Ownership
-
Established
2022-07-21
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

2

NMPA:2

Drug Approvals

Ibuprofen Suspension Drops

Product Name
布洛芬混悬滴剂
Approval Number
国药准字H20249217
Approval Date
Oct 29, 2024
NMPA

Ibuprofen Suspension

Product Name
布洛芬混悬液
Approval Number
国药准字H20243841
Approval Date
May 28, 2024
NMPA

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.